Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses (Q45844050)

16 December 2017

title

Serum cytokine profile in adalimumab-treated refractory uveitis patients: decreased IL-22 correlates with clinical responses (English)

1 reference

16 December 2017

0 references

1 reference

Miguel Cordero-Coma

1

1 reference

16 December 2017

Sara Calleja

2

1 reference

16 December 2017

Milagros Llorente

3

1 reference

16 December 2017

Esther Rodriguez

4

1 reference

16 December 2017

Manuel Franco

5

1 reference

16 December 2017

Jose G Ruiz de Morales

6

1 reference

16 December 2017

publication date

25 April 2013

1 reference

16 December 2017

Ocular Immunology and Inflammation

published in

1 reference

16 December 2017

volume

21

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

page(s)

212-219

1 reference

16 December 2017

C-reactive protein serum levels in patients with ocular disease.

cites work

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Erythrocyte sedimentation rate, C-reactive protein level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Cytokines in autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

The role of soluble TNF receptors for TNF-alpha in uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Elevated levels of interleukin 6 in the vitreous fluid of patients with pars planitis and posterior uveitis: the Massachusetts eye & ear experience and review of previous studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

High levels of interleukin-12 in the aqueous humor and vitreous of patients with uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Intraocular interleukin-17 and proinflammatory cytokines in HLA-A29-associated birdshot chorioretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Serum cytokine levels in active uveitis and remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Upregulated IL-23 and IL-17 in Behçet patients with active uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Upregulation of interleukin 21 and promotion of interleukin 17 production in chronic or recurrent Vogt-Koyanagi-Harada disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Elevated serum IL-23 correlates with intraocular inflammation after cataract surgery in patients with Vogt-Koyanagi-Harada disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Clinical review: Anti-TNFalpha therapies in uveitis: perspective on 5 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Adalimumab specifically induces CD3(+) CD4(+) CD25(high) Foxp3(+) CD127(-) T-regulatory cells and decreases vascular endothelial growth factor plasma levels in refractory immuno-mediated uveitis: a non-randomized pilot intervention study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Serum levels of IL-17 and IL-22 are reduced by etanercept, but not by acitretin, in patients with psoriasis: a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

Cytokine profiles during infliximab monotherapy in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09273948.2013.770888

10.3109/09273948.2013.770888

21 January 2018

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017